MedTech Dive May 11, 2022
Elise Reuter

Medical device companies saw procedures bounce back at the end of the first quarter after a surge of COVID-19 cases at the start of the 2022.

Multiple companies, including GE Healthcare, Intuitive Surgical and Zimmer Biomet, reported a pattern of declining procedure volumes in January — curbed by rising COVID-19 cases — before seeing a recovery in February and March.

Still, medical device firms also flagged several challenges ahead, including shortages of semiconductors and other equipment, rising transportation costs and continued hospital staffing woes

Starting off the earnings season, Johnson & Johnson’s CFO Joseph Wolk said the medtech business experienced a “faster recovery than we anticipated,” with the company noting that diagnostic volumes and surgical volumes were trending up. That...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Supply Chain, Technology
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article